2008
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants
Görk A, Ehrenkranz R, Bracken M. Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. 2008, 2010: cd006071. PMID: 18254092, PMCID: PMC8912238, DOI: 10.1002/14651858.cd006071.pub2.Peer-Reviewed Original ResearchConceptsSymptomatic patent ductus arteriosusPatent ductus arteriosusTreatment of PDAContinuous indomethacin infusionRetinopathy of prematurityPDA closurePreterm infantsBolus administrationBolus injectionBlood flowBronchopulmonary dysplasiaIndomethacin infusionIntraventricular hemorrhagePremature infantsContinuous infusionMesenteric circulationRelative riskRisk differencePatent ductus arteriosus closureCerebral blood flow velocityAdverse effectsCochrane Neonatal reviewsContinuous infusion groupIntermittent bolus dosesSymptomatic preterm infants
1998
Maternal anthropometric factors and risk of primary cesarean delivery.
Shepard M, Saftlas A, Leo-Summers L, Bracken M. Maternal anthropometric factors and risk of primary cesarean delivery. American Journal Of Public Health 1998, 88: 1534-8. PMID: 9772858, PMCID: PMC1508477, DOI: 10.2105/ajph.88.10.1534.Peer-Reviewed Original ResearchConceptsBody mass indexCesarean deliveryPrimary cesarean deliveryMass indexWeight gainPrepregnancy weightProportional weight gainUnderweight womenPrepregnancy body mass indexBody mass index groupsHigher body mass indexMaternal anthropometric factorsGestational weight gainOutcome risk factorsGreater New HavenAbsolute weight gainSingleton deliveriesGestational weightVaginal deliveryProspective studyPrimary cesareanRisk factorsRelative riskAnthropometric factorsIndex group
1994
Clinically useful measures of effect in binary analyses of randomized trials
Sinclair J, Bracken M. Clinically useful measures of effect in binary analyses of randomized trials. Journal Of Clinical Epidemiology 1994, 47: 881-889. PMID: 7730891, DOI: 10.1016/0895-4356(94)90191-0.Peer-Reviewed Original ResearchConceptsOdds ratioTreatment effectsHigher baseline riskRelative risk reductionRandomized clinical trialsControl group risksGroups of trialsLarge treatment effectsPhysician appreciationRandomized trialsRisk ratioClinical trialsRelative riskBaseline riskTreatment decisionsClinical questionsRisk differenceTrialsSingle trialRisk reductionRiskGroup riskPhysiciansAbsolute effectUseful measure
1992
Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid
Ballard R, Ballard P, Bracken M, Moya F, Gross I, Creasy K, Padbury J, Polk D. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. The Lancet 1992, 339: 510-515. PMID: 1346877, DOI: 10.1016/0140-6736(92)90337-3.Peer-Reviewed Original ResearchMeSH KeywordsBetamethasoneChronic DiseaseDouble-Blind MethodDrug Therapy, CombinationFemaleHumansInfant, Low Birth WeightInfant, NewbornInfant, Premature, DiseasesLung DiseasesMalePregnancyPrenatal CareRespiration, ArtificialRespiratory Distress Syndrome, NewbornRisk FactorsThyrotropin-Releasing HormoneConceptsChronic lung diseaseThyrotropin-releasing hormoneRespiratory distress syndromePrenatal thyrotropin-releasing hormoneDistress syndromePostconceptional ageBirthweight infantsLung diseaseSevere respiratory distress syndromeSteroid-alone groupNeonatal respiratory morbidityComplications of prematurityUnadjusted relative riskPrenatal glucocorticoid treatmentWeeks postconceptional ageTRH therapyPreterm deliveryRespiratory morbidityWeeks' gestationGlucocorticoid treatmentNeonatal periodAdverse outcomesTotal incidencePrenatal treatmentRelative risk
1991
Premature rupture of membranes at preterm. Meta-analysis of the effect of steroids on the prevention of respiratory distress syndrome.
Oyarzún E, Gómez R, Romero R, Bracken M. Premature rupture of membranes at preterm. Meta-analysis of the effect of steroids on the prevention of respiratory distress syndrome. Revista Medica De Chile 1991, 119: 388-95. PMID: 1842981.Peer-Reviewed Original ResearchConceptsRespiratory distress syndromeFetal respiratory distress syndromeUse of steroidsPremature ruptureDistress syndromeEffects of steroidsInfectious complicationsSteroid treatmentPregnant womenRelative riskSteroidsSyndromeConfidence intervalsComplicationsRupturePretermNeonatesPatientsPreventionWomen
1987
THE ASSOCIATION BETWEEN LOW BIRTH WEIGHT AND CAFFEINE CONSUMPTION DURING PREGNANCY
MARTIN T, BRACKEN M. THE ASSOCIATION BETWEEN LOW BIRTH WEIGHT AND CAFFEINE CONSUMPTION DURING PREGNANCY. American Journal Of Epidemiology 1987, 126: 813-821. PMID: 3661529, DOI: 10.1093/oxfordjournals.aje.a114718.Peer-Reviewed Original ResearchConceptsLow birth weightBirth weightGestational ageCaffeine intakeCaffeine consumptionYale-New Haven HospitalMaternal caffeine intakeMean birth weightWeeks gestational ageAntenatal patientsSingleton newbornsTerm newbornsProspective studyCaffeine dailyRelative riskCaffeine exposureGrowth retardationDose responseNewbornsIntakeAgeRiskPregnancyPatientsHospital
1986
ASSOCIATION OF LOW BIRTH WEIGHT WITH PASSIVE SMOKE EXPOSURE IN PREGNANCY1
MARTIN T, BRACKEN M. ASSOCIATION OF LOW BIRTH WEIGHT WITH PASSIVE SMOKE EXPOSURE IN PREGNANCY1. American Journal Of Epidemiology 1986, 124: 633-642. PMID: 3752056, DOI: 10.1093/oxfordjournals.aje.a114436.Peer-Reviewed Original ResearchConceptsLow birth weightPassive smoke exposureBirth weightPassive smokingTerm deliverySmoke exposureYale-New Haven HospitalUnexposed womenAntenatal patientsTerm newbornsPassive smokeGestational ageCigarette smokingProspective studyRelative riskSmokingGrowth retardationPregnancyAdditive effectRiskWomenExposureSmokeDeliveryNonsmokersCaffeine consumption during pregnancy and association with late spontaneous abortion
Srisuphan W, Bracken M. Caffeine consumption during pregnancy and association with late spontaneous abortion. American Journal Of Obstetrics And Gynecology 1986, 154: 14-20. PMID: 3946486, DOI: 10.1016/0002-9378(86)90385-6.Peer-Reviewed Original ResearchConceptsSecond-trimester spontaneous abortionSpontaneous abortionPregnant womenCaffeine consumptionHeavy caffeine consumptionProspective cohort studyLate spontaneous abortionsAverage daily intakeLast pregnancyCohort studyMedical historyCaffeine dailyRelative riskContraceptive useAssociation of caffeineDrinking habitsSources of caffeineDaily intakeCaffeine usePregnancyCaffeine usersDemographic characteristicsWomenAbortionAssociation